Revolution Medicines Inc
RVMD
Market Cap$6.83B
Close$
$2.43
93.4% downside
Current Fair Value
93.4% downsideOvervalued by 93.4% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $6.83 Billion |
|---|---|
| Enterprise Value | $6.43 Billion |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-3.58 |
| Beta | 1.37 |
| Outstanding Shares | 167,737,672 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -10.28 |
|---|---|
| PEG | -23.28 |
| Price to Sales | - |
| Price to Book Ratio | 2.84 |
| Enterprise Value to Revenue | 8661.65 |
| Enterprise Value to EBIT | -9.8 |
| Enterprise Value to Net Income | -12 |
| Total Debt to Enterprise | 0.02 |
| Debt to Equity | 0.06 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Revolution Medicines Inc
CEO: Mark Goldsmith